Clinical Features and Therapeutic Evaluation of Central Nervous System Involvement in Pediatric Anaplastic Large Cell Lymphoma
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.31922 ↗At a glance
Journal article in Pediatric Blood & Cancer, 2025. Written by Xiaomei Yang and 29 co-authors. Institution: Department of Pediatric Hematology/Oncology, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital), Jinan, China. Major MEDLINE topics: Lymphoma, Large-Cell, Anaplastic, Central Nervous System Neoplasms, Antineoplastic Combined Chemotherapy Protocols. 33 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: pediatric medical coordinated development center of Beijing Children's Hospital Authority.
Abstract (original language)
Background
This study analyzed the clinical features of central nervous system involvement (CNS3) in pediatric anaplastic large cell lymphoma (ALCL) and evaluated the CNCL‐ALCL‐2017 treatment protocol efficacy.
Methods
The clinical data of 215 pediatric ALCL patients aged ≤18 years, including 16 with CNS3, treated following the CNCL‐ALCL‐2017 protocol, were enrolled. Independent risk factors of CNS3 were determined using multi‐factor logistic regression analysis, and survival curves were constructed.
Results
Brain parenchyma/spinal cord involvement, cranial nerve deficits, and cerebrospinal fluid (CSF) positivity were found in 11/16, 5/16, and 7/16 CNS3 patients, respectively, the latter including six positive on flow cytometry, one NPM1‐ALK positive on PCR. Immunohistochemistry showed ALK and CD3 positivity in 15/16 and 13/16 patients, respectively. Peripheral blood ALK + and bone marrow ALK + were found in 10/16 and 9/16 patients, respectively. All CNS3 patients were treated with Regimen C. Multi‐factor logistic regression analysis identified ear, nose, and throat involvement and CD3 expression as independent risk factors of CNS involvement. The median follow‐up period was 35.4 months (range: 0.5–74.9 months).
Conclusions
The 3‐year overall and event‐free survivals for the CNS3 group were 93.3% ± 6.4% and 86.2% ± 9.1%, respectively, with no differences from the whole cohort.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pediatric Hematology/Oncology, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital), Jinan, China.
- Medical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
- Department of Hematology, Hunan Children's Hospital, Changsha, China.
- Department of Pediatric Lymphoma, Beijing Gobroad Boren Hospital, Beijing, China.
- Department of Pediatrics Hematology and Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Department of Hematologic Oncology, Xi'an Children's Hospital, Xi'an, China.
ORCID profiles: Xiaomei Yang, Luping Ding, Lijun Qu
Funding
- pediatric medical coordinated development center of Beijing Children's Hospital Authority
Cite
APA
Yang, X., Yang, J., Huang, S., Duan, Y., Jin, L., Du, L., Ding, L., Zheng, M., Wu, P., Liu, Y., Hu, B., Dai, Y., Guan, G., Liu, A., Qin, S., Zhang, L., Jia, Y., Sun, L., Jiang, J., …, & Zhang, Y. (2025). Clinical Features and Therapeutic Evaluation of Central Nervous System Involvement in Pediatric Anaplastic Large Cell Lymphoma. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31922
Vancouver
Yang X, Yang J, Huang S, Duan Y, Jin L, Du L, et al. Clinical Features and Therapeutic Evaluation of Central Nervous System Involvement in Pediatric Anaplastic Large Cell Lymphoma. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31922
BibTeX
@article{Yang2025,
author = {Yang, Xiaomei and Yang, Jing and Huang, Shuang and Duan, Yanlong and Jin, Ling and Du, Lian and Ding, Luping and Zheng, Mincui and Wu, Pan and Liu, Ying and Hu, Bo and Dai, Yunpeng and Guan, Guotao and Liu, Ansheng and Qin, Shuang and Zhang, Leping and Jia, Yueping and Sun, Lirong and Jiang, Jian and Wang, Jian and Qu, Lijun and Yuan, Xiaojun and Dong, Yushuang and Liu, Wei and Zhou, Jianwen and Zhang, Baoxi and Zhou, Chunju and Gao, Zifen and Li, Fu and Zhang, Yonghong},
title = {Clinical Features and Therapeutic Evaluation of Central Nervous System Involvement in Pediatric Anaplastic Large Cell Lymphoma},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.31922}
}
EUVIMED